STAT+: FDA rejects an industry proposal to deregulate some AI devices
In this edition of Health Tech: FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.
In this edition of Health Tech: FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.